{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:03:23Z","timestamp":1761102203055,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.nmd.2016.07.006","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T18:30:48Z","timestamp":1469039448000},"page":"801-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["SWORD: A simplified desensitization protocol for enzyme replacement therapy in adult Pompe disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Laure","family":"Gallay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Petiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Streichenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Berard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.nmd.2016.07.006_bib0010","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"Van der Ploeg","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.nmd.2016.07.006_bib0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ymgme.2009.07.001","article-title":"Desensitization of an adult patient with Pompe disease and a history of anaphylaxis to alglucosidase alfa","volume":"98","author":"Lipinski","year":"2009","journal-title":"Mol Genet Metab"},{"issue":"1\u20132","key":"10.1016\/j.nmd.2016.07.006_bib0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymgme.2011.07.004","article-title":"An individually, modified approach to desensitize infants and young children with Pompe disease, and significant reactions to alglucosidase alfa infusions","volume":"104","author":"El-Gharbawy","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.nmd.2016.07.006_bib0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.aller.2013.02.012","article-title":"Desensitisation of the youngest patient with Pompe disease in response to alglucosidase alfa","volume":"42","author":"Karagol","year":"2014","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"3","key":"10.1016\/j.nmd.2016.07.006_bib0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/GIM.0b013e31819d0996","article-title":"Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease","volume":"11","author":"Nicolino","year":"2009","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.nmd.2016.07.006_bib0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","article-title":"Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease","volume":"66","author":"Kishnani","year":"2009","journal-title":"Pediatr Res"},{"issue":"11","key":"10.1016\/j.nmd.2016.07.006_bib0040","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","article-title":"General considerations on rapid desensitization for drug hypersensitivity \u2013 a consensus statement","volume":"65","author":"Cernadas","year":"2010","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.nmd.2016.07.006_bib0045","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.nmd.2016.07.006_bib0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.immuni.2008.02.008","article-title":"Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis","volume":"28","author":"Tsujimura","year":"2008","journal-title":"Immunity"},{"issue":"30","key":"10.1016\/j.nmd.2016.07.006_bib0055","doi-asserted-by":"crossref","first-page":"12413","DOI":"10.1073\/pnas.1105695108","article-title":"Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis","volume":"108","author":"Khodoun","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.nmd.2016.07.006_bib0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.anai.2012.10.006","article-title":"Successful desensitization in a type VI mucopolysaccharidosis patient with probable IgE-mediated allergy to galsulfase [Naglazyme]","volume":"110","author":"B\u00e9gin","year":"2013","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616300475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616300475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:05:01Z","timestamp":1760774701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896616300475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0960896616300475"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2016.07.006","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SWORD: A simplified desensitization protocol for enzyme replacement therapy in adult Pompe disease","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2016.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}